Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antimony exposure induces bladder cancer metastasis via activation of the SUMOylation-dependent TGF-β/Smad2/3 axis. | Environ Res | 2025 | 40812700 | PubTator, text mining | PubMed |
| Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases. | Anim Cells Syst (Seoul) | 2025 | 40735528 | PubTator, text mining | PubMed |
| SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation. | Cell Death Dis | 2025 | 40651945 | PubTator, text mining | PubMed |
| UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis. | Int J Mol Sci | 2025 | 40650059 | PubTator, text mining | PubMed |
| Structural basis for a nucleoporin exportin complex between RanBP2, SUMO1-RanGAP1, the E2 Ubc9, Crm1 and the Ran GTPase. | Nat Commun | 2025 | 40640138 | PubTator, text mining | PubMed |
| UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2. | World J Surg Oncol | 2025 | 40635031 | PubTator, text mining | PubMed |
| DNA polymerase α/primase extraction from chromatin by VCP/p97 restricts ATR activation during unperturbed DNA replication. | Nat Commun | 2025 | 40593507 | PubTator, text mining | PubMed |
| SENP1 Senses Oxidative Stress to Regulate the SUMOylation Modification of ZIP8 and Maintain Zinc Transport Functions. | Antioxidants (Basel) | 2025 | 40563382 | PubTator, text mining | PubMed |
| SUMOylation is a Translatable Target in Hypoxic MNPs Regulating Retinal Vasculopathy. | Adv Sci (Weinh) | 2025 | 40448612 | PubTator, text mining | PubMed |
| Unveiling the dynamic drivers: phase separation's pivotal role in stem cell biology and therapeutic potential. | Stem Cell Res Ther | 2025 | 40442783 | PubTator, text mining | PubMed |
| Crosstalk between SUMOylation and ubiquitination controls the stability of transcription factor zinc finger protein 24: a novel antitumor mechanism in bladder cancer. | Oncogene | 2025 | 40437183 | PubTator, text mining | PubMed |
| Integrative multi-omics and Mendelian randomization analysis reveal SPP1+ tumor-associated macrophage-driven prognostic signature for hepatocellular carcinoma. | Front Mol Biosci | 2025 | 40376263 | PubTator, text mining | PubMed |
| Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation. | Sci Adv | 2025 | 40367183 | PubTator, text mining | PubMed |
| Biochemical Mechanisms of Genetic Recombination and DNA Repair. | Annu Rev Biochem | 2025 | 40153609 | PubTator, text mining | PubMed |
| Elevated UBC9 expression and its oncogenic role in colorectal cancer progression and chemoresistance. | Sci Rep | 2025 | 40097547 | PubTator, text mining | PubMed |
| UBC9: a novel therapeutic target in papillary thyroid carcinoma. | J Endocrinol Invest | 2025 | 40025314 | PubTator, text mining | PubMed |
| Non-Invasive Assessment of Neurogenesis Dysfunction in Fetuses with Early-Onset Growth Restriction Using Fetal Neuronal Exosomes Isolating from Maternal Blood: A Pilot Study. | Int J Mol Sci | 2025 | 40003962 | PubTator, text mining | PubMed |
| Disruption of oocyte SUMOylation impacts critical regulatory processes during folliculogenesis in mice†. | Biol Reprod | 2025 | 39982420 | PubTator, text mining | PubMed |
| Chemical approaches to explore ubiquitin-like proteins. | RSC Chem Biol | 2025 | 39950163 | PubTator, text mining | PubMed |
| Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk. | Hepatology | 2025 | 39932259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=4